Friday, 22 October 2010

British schoolboy expose phony drugs via Twitter

A 15-year-old teenager from Wales has led to a global Internet campaign against a bogus "panacea" after posting warnings about it on the social networking site Twitter. Skip related contentRhys Morgan, a 15-year-old who suffers from the disease Crohn's disease, stumbled upon a substance called Miracle Mineral Solution (MMS) while looking for treatment for his condition, which causes swelling in the digestive tract.

"I heard about it while browsing a support forum for the Crohn's disease, which I was diagnosed with earlier this year," said Morgan AFP.

Morgan's Search led him to a website run by the apparent drug maker of Jim Humble MMS assert that "the answer was on AIDS, hepatitis A, B and C, tuberculosis, herpes, TB, most cancers and much more from humanity worse diseases".

The website also claims that MMS has been tested on more than 75,000 people in Africa and that Humble personally more than 2000 malaria victims with the medicinal product.
Soon After, Morgan found a reference to the drug on the u.s. food and Drug Administration website.

The Agency warned, "the product, when used as prescribed, produces an industrial bleach that result in serious damage to health to can."

UK Food Standards Agency posted later a similar announcement about the product, which States that "when taken as it can lead to severe nausea, vomiting, and diarrhea."

Rhys began warnings about MMS on his Twitter page, and the number of people at night after his tweets upwards of 150 to 350. He also began to complain about the medicinal Britain's Trading Standards agency.

Of the Cardiff schoolchild warning has since been picked up by science writers in the British media and re-tweeted to thousands of their readers.

Modest was not immediately available for comment.

When asked what he wants to say Humble if he got the chance, Morgan said: "I would ask him to think about what he's doing and critical thinking about its product."


View the original article here

No comments:

Post a Comment